These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15632331)

  • 1. High-dose statins in acute coronary syndromes.
    Davidson MH
    JAMA; 2005 Jan; 293(1):38; author reply 38-9. PubMed ID: 15632331
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of elastic properties of magistral arteries in patients with ischemic heart disease during treatment with atorvastatin and simvastatin].
    Iliukhin OV; Kalganova EL; Babkin AA; Lopatin IuM
    Kardiologiia; 2005; 45(12):31-4. PubMed ID: 16353044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose statins in acute coronary syndromes.
    Mitchel YB
    JAMA; 2005 Jan; 293(1):37; author reply 38-9. PubMed ID: 15632330
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003.
    Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG
    Atheroscler Suppl; 2004 Oct; 5(3):115-23. PubMed ID: 15531284
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of lipid-modulating drugs in complicated course of coronary heart disease.
    Gratsianskii NA; Vaulin NA
    Bull Exp Biol Med; 2007 Sep; 144(3):438-46. PubMed ID: 18457052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comment from the cardiologic viewpoint].
    Lüscher TF
    Praxis (Bern 1994); 2009 Feb; 98(3):129-30. PubMed ID: 19180438
    [No Abstract]   [Full Text] [Related]  

  • 7. Heat shock protein antibody titers are reduced by statin therapy in dyslipidemic subjects: a pilot study.
    Ghayour-Mobarhan M; Lamb DJ; Vaidya N; Livingstone C; Wang T; Ferns GA
    Angiology; 2005; 56(1):61-8. PubMed ID: 15678257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atherosclerosis in light of the evidence from large statin trials].
    Cortese C; Bernardini S; Motti C
    Ann Ital Med Int; 2000; 15(1):103-7. PubMed ID: 10842899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose statins in acute coronary syndromes.
    Isley WL
    JAMA; 2005 Jan; 293(1):37-8; author reply 38-9. PubMed ID: 15632329
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose statins in acute coronary syndromes.
    Ovbiagele B
    JAMA; 2005 Jan; 293(1):36-7; author reply 38-9. PubMed ID: 15632327
    [No Abstract]   [Full Text] [Related]  

  • 11. Study highlights need for considered clinical approach to statin switching.
    Lloyd K
    Int J Clin Pract; 2007 May; 61(5):880; author reply 880-1. PubMed ID: 17493097
    [No Abstract]   [Full Text] [Related]  

  • 12. More on switching statins: comments from Pfizer.
    Lloyd K
    BMJ; 2006 Sep; 333(7569):655; author reply 655-6. PubMed ID: 16990337
    [No Abstract]   [Full Text] [Related]  

  • 13. Atorvastatin for acute coronary syndromes.
    Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR
    JAMA; 2001 Aug; 286(5):533-5. PubMed ID: 11476650
    [No Abstract]   [Full Text] [Related]  

  • 14. A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
    Wiviott SD; de Lemos JA; Cannon CP; Blazing M; Murphy SA; McCabe CH; Califf R; Braunwald E
    Circulation; 2006 Mar; 113(11):1406-14. PubMed ID: 16534008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose statins in acute coronary syndromes.
    Crouse JR
    JAMA; 2005 Jan; 293(1):36; author reply 38-9. PubMed ID: 15632328
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.
    Choudhry NK; Levin R; Winkelmayer WC
    Heart; 2007 Aug; 93(8):945-51. PubMed ID: 17344334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
    Pedersen TR; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Bendiksen FS; Lindahl C; Szarek M; Tsai J;
    JAMA; 2005 Nov; 294(19):2437-45. PubMed ID: 16287954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of endothelial function in patients with metabolic syndrome on bezafibrate or atorvastatin therapy.
    Hanefeld C; Bulut-Streich N; Bulut D; Graf C; Mügge A; Spiecker M
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):153-5. PubMed ID: 16025235
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins and stroke: current clinical practice.
    Castilla-Guerra L; Espino-Montoro A; Fernandez Moreno Mdel C; López-Chozas JM; Jimérnez MD
    Stroke; 2006 May; 37(5):1153. PubMed ID: 16556875
    [No Abstract]   [Full Text] [Related]  

  • 20. Statins for COPD: a challenge to conventional beliefs?
    Pearson M
    Prim Care Respir J; 2012 Mar; 21(1):5-7. PubMed ID: 22349920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.